Current knowledge on the role of H2S in the pathogenesis of PAH is limited to data showing increased CSE activity in a hypoxia-induced PAH model [138], which was not confirmed in another study [139], and evidence that H2S donors exert a protective effect by inhibiting EndMT [140]. The gene discussed is SLC2A1; the disease is pulmonary arterial hypertension.